
HER2 Evolution in Gastroesophageal Cancer: New Therapies and Optimized Outcomes
12/1/2025
0:00
27:15
Learn which HER2-targeted therapies are being evaluated for the first-line treatment of gastroesophageal adenocarcinoma.
Credit available for this activity expires: 11/27/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/her2-evolution-gastroesophageal-cancer-new-therapies-and-2025a1000x2t?ecd=bdc_podcast_libsyn_mscpedu
More episodes from "Keeping Current CME"



Don't miss an episode of “Keeping Current CME” and subscribe to it in the GetPodcast app.







